Waters
Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021
While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price.
GW Index Rises 3 Percent in December
Waters and Bio-Techne rebounded after falling in November, but Burning Rock and Genetron both saw sharp declines.
Waters Q3 Revenues Rise 11 Percent
Waters posted revenues of $659.2 million in Q3, compared to $593.8 million in Q3 2020 and beating the average Wall Street estimate of $656.5 million.
Waters Q2 Revenues up 31 Percent
The company posted revenues of $681.6 million, up 31 percent from $520.0 million in Q2 2020, and above the average Wall Street estimate of $621.5 million.
Evercore ISI Upgrades Waters to Outperform Based on Improved Fundamentals
The analysts cited opportunity in drug QC provided by Biogen's aducanumab approval as well as a new focus on markets like CROs and CDMOs.
Jun 23, 2021
Jun 18, 2021
May 5, 2021
Waters Posts 31 Percent Increase in Q1 Revenues
Oct 27, 2020
Waters Q3 Revenues Up 3 Percent
Jun 12, 2020
Apr 28, 2020
Waters Q1 Revenues Down 10 Percent
Jan 15, 2020
Jan 2, 2020
Oct 29, 2019